| Ytd | -18.09% | |
| 1y | -36.67% |
| Open | 3.31 | Prev Close | 3.29 | Low | 3.27 | High | 3.42 | Mkt Cap | 1.76B |
| Vol | 10.95M | Avg Vol | 20.94M | EPS | -1.04 | P/E | -3.22 | Forward P/E | -3.53 |
| Beta | 1.05 | Short Ratio | 7.68 | Inst. Own | 72.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 3.31 | 200-d Avg | 3.82 | 1yr Est | 7.25 |
RXRX News
Recursion Pharmaceuticals, Inc. (RXRX) Presents at Bank of America SMID Cap Virtual Conference Trans
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth chall
Recursion misses Q2 earnings and revenue estimates as collaboration revenues fall year over year, se
Recursion Pharmaceuticals NASDAQ: RXRX outlined progress across its clinical pipeline, drug-discover
Recursion Pharmaceuticals, Inc. (RXRX) Q2 2026 Earnings Call Transcript
Recursion Pharmaceuticals (RXRX) came out with a quarterly loss of $0.25 per share versus the Zacks
Genentech advanced the collaboration's first neuroscience target into a joint early discovery progra
Salt Lake City, UT, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-s
Salt Lake City, UT, July 31, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical s
Analysts remain optimistic that the market will view upcoming catalysts in a bullish light.
The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $2.97, representing a -2.62%
Salt Lake City, UT, July 29, 2026 (GLOBE NEWSWIRE) -- Salt Lake City, UT, July 29, 2026 (GLOBE NEWSW
In the closing of the recent trading day, Recursion Pharmaceuticals (RXRX) stood at $3.01, denoting
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to W
Amova Asset Management Americas Inc. decreased its position in shares of Recursion Pharmaceuticals,
In the closing of the recent trading day, Recursion Pharmaceuticals (RXRX) stood at $2.89, denoting
In the most recent trading session, Recursion Pharmaceuticals (RXRX) closed at $3.34, indicating a +
Recursion Pharmaceuticals has yet to prove that its approach to developing medicines is superior. Sa
Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.72, moving 3.13% from the
Oncology innovation is reshaping cancer care as AI, immunotherapy and targeted therapies fuel pipeli
Two stocks that have fallen out of favor and one hot stock that was one of Thursday's biggest losers
Anthropic launches Claude Science for researchers as PwC data shows AI mentions in pharma M&A de
Here's a look at the earnings calendar for the week ahead, including reports from Nvidia, Joby,
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pr
Gainers
Friday's session saw 104 companies set new 52-week lows.
On Thursday, 185 companies achieved new lows for the year.
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
On Wednesday, 807 companies reached new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
On Monday, 671 companies achieved new lows for the year.